CD8-deficient mice exhibit augmented mucosal immune responses and intact adjuvant effects to cholera toxin

Immunology

Volumn 87, Issue 2, 1996, Pages 220-229

  Hornquist E ^a   Grdic D ^a   Mak, T ^b   Lycke, N ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CHOLERA TOXIN; CYTOKINE; GAMMA INTERFERON; KEYHOLE LIMPET HEMOCYANIN;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; B LYMPHOCYTE; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNE RESPONSE; IMMUNIZATION; MACROPHAGE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0030023828     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.1996.473536.x     Document Type: Article

References (43)

1. LYCKE N. & SVENNERHOLM A.-M. (1990) Presentation of immunogens at the gut and other mucosal surfaces. In: New Genetic Vaccines (eds G. Woodrow & M. Levine), p. 217. Dekker, New York.
2. MCGHEE J.R., MESTECKY J., DERTZBAUGH M.T., ELDRIDGE J.H., HIRASAWA M. & KIYONO H. (1992) The mucosal immune system: from fundamental concepts to vaccine development. Vaccine 10, 75.
3. GUY-GRAND D. & VASSALLI P. (1993) Gut intraepithelial T lymphocytes. Curr Opin Immunol 5, 247.
4. RICHMAN L.K., CHILLER J.M., BROWN W.R., HANSON D.G. & VAZ N.M. (1978) Enterically induced immunologic tolerance. J Immunol 121, 2429.
5. NGAN J. & KIND L.S. (1978). Suppressor T cells for IgE and IgG in Peyer's patches of mice made tolerant by oral administration of ovalbumin. J Immunol 120, 861
6. MILLER A., LIDER O., ROBERTS A.B., SPORN M.B. & WEINER H.L. (1992) Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth β after antigen-specific triggering. Proc Natl Acad Sci USA 89, 421.
7. + T cells regulate the IgE response and protective immunity in mice. Exp Parasitol 73, 500.
8. SADLACK B., MERZ H., SCHORLE H., SCHIMPL A., FELLER A.C. & HORAK I. (1993) Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 75, 253.
9. KÜHN R., LÖHLER J., RENNICK D., RAJEWSKY K. & MÜLLER W. (1993) Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75, 263.
10. MOMBAERTS P., MIZOGUCHI E., GRUSBY M.J., GLIMCHER L.H., BHAN A.K. & TONEGAWA S. (1993) Spontaneous development of inflammatory bowel disease in T cell receptor mutant mice. Cell 75, 275.
11. HÖRNQUIST E., LYCKE N., CZERKINSKY C. & HOLMGREN J. (1993) Cholera toxin and cholera B subunit as oral-mucosal adjuvant and antigen carrier systems. In: Novel delivery systems for oral vaccines. (ed. D.T. O'Hagan), p.153. CRC Press, Boca Raton.
12. NEDRUD J.G & LAMM M. (1991) Adjuvants and the mucosal immune system. In: Topics in Vaccine Adjuvant Research, (eds D.R. Spriggs & W.C. Koff), p. 51. CRC Press, Boca Raton.
13. ELSON C.O. & EALDING W. (1984) Generalized systemic and mucosal immunity in mice after mucosal stimulation with cholera toxin. J Immunol 132, 2736.
14. LYCKE N. & HOLMGREN J. (1986) Strong adjuvant properties of cholera toxin on gut mucosal immune responses to orally presented antigens. Immunology 59, 301.
15. LIANG X., LAMM M.E. & NEDRUD J.G. (1988) Oral administration of cholera toxin-Sendai virus conjugate potentiates gut and respiratory immunity against Sendai virus. J Immunol 141, 1495.
16. BROMANDER A.K, HOLMGREN J. & LYCKE N. (1991) Cholera toxin stimulates IL-1 production and enhances antigen presentation by macrophages in vitro. J Immunol 146, 2908.
17. HÖRNQUIST E. & LYCKE N. (1993) Cholera toxin adjuvant greatly promotes antigen priming of T cells. Eur J Immunol 23, 2136.
18. LYCKE N. (1993) Cholera toxin promotes B cell isotype switching by two different mechanisms. cAMP induction augments germ-line Ig H-chain RNA transcripts whereas membrane ganglioside GM1-receptor binding enhances later events in differentiation. J Immunol 150, 4810.
19. + cells but markedly decreased helper cell activity in mice lacking CD4. Nature 353, 180.
20. FUNG-LEUNG W.-P., SCHILHAM M.W., RAHEMTULLA A. et al. (1991) CD8 is needed for development of cytotoxic T cells but not helper T cells. Cell 65, 443.
21. + lamina propria T-cell lines: phenotypic and functional characterization. Immunology 75, 66.
22. LYCKE N. (1986) A sensitive method for the detection of specific antibody production in different isotypes from single lamina propria plasma cells. Scand J Immunol 24, 393.
23. + T cell dependent. Infect Immun 59, 3630.
24. HARRIMAN G.R., LYCKE N.Y., ELWOOD L.J & STROBER W. (1990) T lymphocytes that express CD4 and the αβ-T cell receptor but lack Thy-1. Preferential localization in Peyer's patches. J Immunol 145, 2406.
25. NORDSTRÖM I. & FERRUA B. (1992) Reverse ELISPOT assay for clonal analysis of cytokine production. II. Enumeration of interleukin-1-secreting cells by amplified (avidin-biotin antiperoxidase) assay. J Immunol Meth 150, 190.
26. MUNOZ E., ZUBIAGA A.M., MERROW M., SAUTER N.P. & HUBER B.T. (1990) Cholera toxin discriminates between T helper 1 and 2 cells in T cell receptor-mediated activation: role of cAMP in T cell proliferation. J Exp Med 172, 95.
27. + T cell subset by cholera toxin (CT) and its B subunit. FASEB J A1864 (abstr).
28. ELSON C.O., HOLLAND S.P., DERTZBAUGH M.T., CUFF C.F. & ANDERSON A.O. (1995) Morphologic and functional alterations of mucosal T cells by cholera toxin and its B subunit. J Immunol 154, 1032.
29. + T cells while decreasing IL-2 release and NF-AT induction. Int Immunol 9, 1333.
30. BRADLEY L.M., CROFT M. & SWAIN S.L. (1993) T-cell memory: new perspectives. Immunol Today 14, 197.
31. MURRAY P.D., MCKENZIE D.T, SWAIN S.L. & KAGNOFF M.F. (1987) Interleukin 5 and interleukin 4 produced by Peyer's patch T cells selectively enhance immunoglobulin A expression. J Immunol 139, 2669.
32. + T lymphocytes: effects of anti-L3T4 treatment on the gastrointestinal immune system. Int Immunol 3, 793.
33. CHALLACOMBE S.J. & TOMASI T.B. (1987) Oral tolerance. In: Food Allergy and Intolerance (eds J. Brostoff & S.J. Challacombe), p. 255. Bailliére Tindall, London.
34. + T cells via T cell receptor -CD3 complex results in interferon-γ and interleukin-5 production, while low density T cells undergo DNA fragmentation. Eur J Immunol 24, 1301.
35. KAUFMANN S., BLUM C. & YAMAMOTO S. (1993) Crosstalk between α/β T cells and γ/δ T cells in vivo: activation of α/β T cell responses after γ/δ T-cell modulation with the monoclonal antibody GL3. Proc Natl Acad Sci USA 90, 9620.
36. ELSON C.O. & EALDING W. (1984) Cholera toxin feeding did not induce oral tolerance in mice and abrogated oral tolerance to an unrelated protein antigen. J Immunol 133, 2892.
37. BOWEN J.C., NAIR S.K., REDDY R. & ROUSE B.T. (1994) Cholera toxin acts as a potent adjuvant for the induction of cytotoxic T-lymphocyte responses with non-replicating antigens. Immunology 81, 338.
38. WILSON A.D., BAILEY M., WILLIAMS N.A. &. STOKES C.R. (1991) The in vitro production of cytokines by mucosal lymphocytes immunized by oral administration of keyhole limpet hemocyanin using cholera toxin as an adjuvant. Eur J Immunol 21, 2333.
39. XU-AMANO J., KIYONO H., JACKSON R. et al. (1993) Helper T cell subsets for immunoglobulin A responses: oral immunization with tetanus toxoid and cholera toxin as adjuvant selectively induces Th2 cells in mucosa associated tissues. J Exp Med 178, 1309.
40. VAJDY M., KOSCO-VILBOIS M., KOPF M., KÖHLER G. & LYCKE N. (1995) Impaired mucosal immune responses in interleukin 4 targeted mice. J Exp Med 191, 41.
41. VAJDY M. & LYCKE N. (1993) Stimulation of antigen-specific T-and B-cell memory in local as well as systemic lymphoid tissues following oral immunization with cholera toxin adjuvant. Immunology 80, 197.
42. LINDHOLM L., HOLMGREN J., LANGE S. & LÖNNROTH I. (1975) Interaction of cholera toxin and toxin derivatives with lymphocytes. Int Arch Allergy Appl Immun 50, 555.
43. GONZALO J.A., GONZÁLEZ-GARCÍA A., BAIXERAS E. et al. (1994) Pertussis toxin interferes with superantigen-induced deletion of peripheral T cells without affecting T cell activation in vivo. J Immunol 152, 4291.